Abstract | BACKGROUND: METHODS: RESULTS: In 19 of the 24 patients, insertion of a metal stent was technically feasible. The 30-day and 60-day mortality rates were 0%. A significant decrease in serum bilirubin was noted in all patients and quality of life remained stable throughout follow-up. Mean and median survival were, respectively, 15.9(3.1) and 9.9: 95% CI [6.4, 13.4] months after photodynamic therapy. In the control group, mean and median survival were, respectively, 12.5(3.4) and 5.6: 95% CI [3.7, 7.6] months, which was not statistically significantly different from the photodynamic therapy group. CONCLUSIONS:
|
Authors | Franz Ludwig Dumoulin, Thomas Gerhardt, Sybille Fuchs, Christian Scheurlen, Michael Neubrand, Günter Layer, Tilman Sauerbruch |
Journal | Gastrointestinal endoscopy
(Gastrointest Endosc)
Vol. 57
Issue 7
Pg. 860-7
(Jun 2003)
ISSN: 0016-5107 [Print] United States |
PMID | 12776033
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Aged
- Bile Duct Neoplasms
(drug therapy, mortality, therapy)
- Bile Ducts, Intrahepatic
- Cholangiocarcinoma
(drug therapy, mortality, therapy)
- Feasibility Studies
- Female
- Humans
- Male
- Middle Aged
- Palliative Care
- Photochemotherapy
- Prospective Studies
- Stents
|